What Science Says About. Fenbendazole. Dieser Artikel ist nicht verfügbar.What Science Says About. Fenbendazole

A dog dewormer that fights cancer — or a viral story science can't yet confirm?

Fenbendazole was developed to clear intestinal worms from livestock. It was never meant for oncology. Yet it belongs to a drug family that targets tubulin — the same protein exploited by some of medicine's most established chemotherapy agents — and laboratory evidence of its effects on cancer cells is real, replicated, and taken seriously by researchers.

What science reveals is more complicated than either believers or skeptics tend to allow. The clinical evidence gap is not a conspiracy; it is a structural consequence of patent economics. The preclinical signal is genuine but bounded. And the distance between mechanism and therapy has swallowed far more promising compounds than this one.

Inside, you'll discover:
– Why fenbendazole's mechanism is scientifically credible — and why credibility is not the same as proof
– What the laboratory studies actually showed, and where their findings stop
– Why the question remains genuinely open, and what answering it would require

What Science Says About... is a series for readers who want evidence, not certainty — explore the full collection.

Read it before drawing conclusions.